Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Intra-Cellular Therapies, Inc.
The study will be conducted in 3 phases: * Screening Period (up to 1 week) during which patient eligibility will be assessed. * Double-blind Treatment Period (3 weeks) during which all eligible patients will be randomized to receive lumateperone 42 mg or placebo in 1:1 ratio. * Safety Follow-up Period (1 week) during which all patients will return to the clinic for a safety follow-up visit
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted